American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013. doi:10.1176/appi.books.9780890425596
2.
PageMJMcKenzieJEBossuytPM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
3.
LeonardHLLenaneMCSwedoSERettewDCRapoportJL.A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting). Arch Gen Psychiatry. 1991;48(9):821-827. doi:10.1001/archpsyc.1991.01810330045007
4.
TurkTLiuCFujiwaraE, et al. Pharmacological interventions for primary psychodermatologic disorders: an evidence mapping and appraisal of randomized controlled trials. J Cutan Med Surg. 2023;27(2):140-149. doi:10.1177/12034754231155888
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
